Document 0669
 DOCN  M94A0669
 TI    Controlled evaluation of a brief intervention for HIV prevention among
       injecting drug users not in treatment.
 DT    9412
 AU    Baker A; Kochan N; Dixon J; Heather N; Wodak A; National Drug and
       Alcohol Research Centre, Kensington, NSW.
 SO    Annu Conf Australas Soc HIV Med. 1993 Oct 28-30;5:48 (abstract no. SE5).
       Unique Identifier : AIDSLINE ASHM5/94348986
 AB    This study evaluated the effectiveness of a brief intervention (BI) in
       reducing HIV risk-taking behaviours among 200 injecting drug users (IDU)
       not enrolled in any form of treatment for drug dependence. Subjects were
       randomly assigned to either a one-session cognitive-behavioural
       intervention or to a no-treatment control condition (C). Follow-up
       occurred at 3 and 6 months. 121 subjects were successfully contacted for
       a 3 month follow-up and 88 subjects were followed up at 6 months. There
       were significant reductions for the sample as a whole for injecting risk
       subscale scores on the HIV Risk-taking Behaviour Scale of the Opiate
       Treatment Index between pre-treatment and follow-up. There was no
       significant change in sexual risk-taking. There were no significant
       differences between groups on any measure at 3- and 6-month follow-up.
       Possible reasons why the sample as a whole showed a significant
       reduction in injecting risk-taking include regression towards the mean,
       changes over time in association with unknown factors and the initial
       assessment acting as a form of BI with all subjects.
 DE    *Cognitive Therapy  Follow-Up Studies  Human  HIV Infections/*PREVENTION
       & CONTROL/TRANSMISSION  Narcotic Dependence/*REHABILITATION  Needle
       Sharing/PSYCHOLOGY  *Psychotherapy, Brief  Risk-Taking  Sex Behavior
       Substance Abuse, Intravenous/*REHABILITATION  Treatment Outcome
       CLINICAL TRIAL  MEETING ABSTRACT  RANDOMIZED CONTROLLED TRIAL

       SOURCE: National Library of Medicine.  NOTICE: This material may be
       protected by Copyright Law (Title 17, U.S.Code).